![]() Genomic Health Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests. | ![]() 23andMe 23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company. | ![]() Natera Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology. | ![]() Abingdon Health Abingdon Health is a specialist medical diagnostics company that acquires, develops and distributes diagnostic tools and services. | ![]() Labcorp Labcorp (also known as Laboratory Corporation of America Holdings) is a life sciences company that provides diagnostic, drug development, and technology-enabled solutions. | ||
Founding Date | Founding Date 2003 | Founding Date 2000 | Founding Date 2006 | Founding Date 2004 | Founding Date 2008 | Founding Date 1995 |
Type | Type Private | Type Subsidiary | Type Public | Type Public | Type Private | Type Subsidiary |
Tags | ||||||
Locations | Locations Palo Alto, US HQ | Locations Redwood City, US HQ Köln, DE Chiyoda City, JP London, GB | Locations Sunnyvale, US HQ South San Francisco, US | Locations Austin, US HQ San Carlos, US | Locations North Yorkshire, GB HQ | |
Employees | Employees 1324% increase | Employees 311 | Employees 56027% decrease | Employees 3,28211% increase | Employees 79 | Employees 70,0004% increase |
Valuation ($) | Valuation ($) 31.5 m | Valuation ($) N/A | Valuation ($) 169.1 m | Valuation ($) 15.4 b | Valuation ($) N/A | Valuation ($) N/A |
Financial | ||||||
Revenue (est.) | Revenue (est.) $100k (Y, 2014) | Revenue (est.) $394.1m (FY, 2018) | Revenue (est.) $189.9m (FY, 2025) | Revenue (est.) $2.3b (FY, 2025) | Revenue (est.) £2.3m (FY, 2018) | Revenue (est.) $13b (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods $89.9m (FY, 2025) | Cost of goods N/A | Cost of goods £583.1k (FY, 2018) | Cost of goods $9.4b (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit $100m (FY, 2025) | Gross profit N/A | Gross profit £1.7m (FY, 2018) | Gross profit $3.6b (FY, 2024) |
Net income | Net income N/A | Net income $25.7m (FY, 2018) | Net income ($280.9m) (FY, 2025) | Net income ($208.2m) (FY, 2025) | Net income £3.5m (FY, 2018) | Net income $747.1m (FY, 2024) |
Operating ⚠ | ||||||
Patent Applications | Patent Applications N/A | Patent Applications N/A | Patent Applications 7 (Apr, 2020) | Patent Applications 100 (FY, 2021) | Patent Applications N/A | Patent Applications N/A |
Patents Issued | Patents Issued N/A | Patents Issued N/A | Patents Issued 93 (FY, 2022) | Patents Issued 200 (FY, 2021) | Patents Issued N/A | Patents Issued N/A |
Funding | ||||||
Latest funding round | Latest funding round $ 100m (over 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 4.8m (about 11 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 1.4b | Total funding raised N/A | Total funding raised $ 912.5m | Total funding raised $ 154.1m | Total funding raised $ 12.9m | Total funding raised $ 350m |

Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests.
View company
23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.
View company
Natera (formerly known as Gene Security Network) is a diagnostics company with proprietary molecular and bioinformatics technology.
View company
Abingdon Health is a specialist medical diagnostics company that acquires, develops and distributes diagnostic tools and services.
View company